VC  First Analysis

http://www.firstanalysis.com





     Office Locations:

One South Wacker Drive, Suite 3900 (39th floor)
Chicago, IL 60606
Phone: 312-258-1400

 

Stages:

  • Expansion
  • Growth


 

Industries:

  • Business Services
  • Energy & Clean Tech
  • Information Technology
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 1981, First Analysis is a leading venture capital investor. The firm has one of the longest records (30 years) in venture capital, having invested more than $825 million across multiple highly diversified funds. First Analysis has over $200 million in active portfolio investments. First Analysis invests mainly in the United States with a focus on Technology / SaaS: Cyber security/infrastructure, e-Commerce / digital engagement, Human capital technology, Internet of things; Healthcare: Medical technology, Pharma technology, Healthcare analytics; Environmental technology: Resource management, Clean-tech / specialty chemicals; and Services: Education, HR & accounting services. The firm invests for expansion and growth in small and mid-size companies with established business models, high internal growth rates, and large-market leadership potential. First Analysis targets investing $3-10 million as lead investor or as a syndicate partner.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Alice Epstein Marketing and Communications Manager
    Clement Erbman Managing Director
    Corey Greendale Managing Director
    Daniel Smereczynski Vice President
    David Gearhart Sr. Vice President

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      09/09/2024


      CSA Medical


      MA


      $53,000,000


      Series D


     

    Portfolio companies include:


      4G Clinical


      Apixio


      AppDetex
        web link


      Blue Medora
        web link


      BuyerQuest
        web link


      Checkpoint Surgical
        web link


      Chrome River
        web link


      CoolR
        web link


      CSA Medical
        web link


      DataSphere
        web link


      Drive My Way


      Edge IQ


      Fortress


      Freeosk
        web link


      Insellerate


      Lender Price


      NimbeLink
        web link


      PCMI


      Recsolu
        web link


      SmartCommerce
        web link


      Stamus Networks
        web link


      StreamLink Software
        web link


      SynergySuite
        web link


      UniversityNow
        web link


      VIDA Diagnostics
        web link


      ViralGains


      Visage.jobs
        web link


      Waggl
        web link


      Yello
        web link


      Yunu


     

    Recent News: